Approval · Notice of Compliance 5043 · 1995
HALFAN: Notice of Compliance 5043
Issued March 29, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5043
- Date
- March 29, 1995
- Company
- Smithkline Beecham Pharma, Inc.Gronau, Saone Et Loire, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antimalarial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALFAN | 02162857 | Cancelled Post Market |
| HALFAN | Not yet assigned | — |
Medicinal ingredients
- HALOFANTRINE HCL 250 MG per TAB
- HALOFANTRINE HCL 20 MG per TAB